Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
How is pharma using advances in technology to its benefit?
What needs to change to improve our odds in the fight against AMR?
What type of dosage form would a patient prefer to take? Additive manufacturing provides the ultimate flexibility.
Why virtual and augmented reality technologies are the future of workforce training.
Jeroen den Hertog from the Hubrecht Institute is exploring the bioactive properties of fungal strains.
A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.
Dale Thomas, Co-founder of Mytide, explains how AI can be used for the discovery and development of peptide therapeutics.
As the new virus spreads, more information is needed to mount an appropriate response.
Bacteria shredding liquid metals to fight drug-resistant superbugs.
Keeping the patient in mind is crucial for clinical research.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.